HIGHLIGHTS
- who: November and colleagues from the Health Research Institute Foundation Jimenez Diaz (IIS-FJD), Spain Isfahan University of Medical have published the paper: Identi cation and validation of a novel cuproptosis-related lncRNA signature for prognosis and immunotherapy of head and neck squamous cell carcinoma, in the Journal: (JOURNAL)
- what: The authors ultimately investigated cuproptosisassociated biomarkers and conducted a CRLs risk model to predict survival outcomes, immune landscape, and chemotherapeutic drug sensitivity in patients with HNSCC. The study provides insights into elucidating the molecular mechanism of CRLs in HNSCC.
- how: To assess the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.